206 related articles for article (PubMed ID: 22735712)
1. Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients.
Alachkar N; Lonze BE; Zachary AA; Holechek MJ; Schillinger K; Cameron AM; Desai NM; Dagher NN; Segev DL; Montgomery RA; Singer AL
Transplantation; 2012 Jul; 94(2):165-71. PubMed ID: 22735712
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients.
Marfo K; Ling M; Bao Y; Calder B; Ye B; Hayde N; Greenstein S; Chapochnick-Friedman J; Glicklich D; de Boccardo G; Kinkhabwala M; Akalin E
Transplantation; 2012 Aug; 94(4):345-51. PubMed ID: 22820699
[TBL] [Abstract][Full Text] [Related]
3. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
[TBL] [Abstract][Full Text] [Related]
4. Desensitizing the broadly human leukocyte antigen-sensitized patient awaiting deceased donor kidney transplantation.
Jordan SC; Reinsmoen N; Lai CH; Cao K; Kahwaji J; Peng A; Villicana R; Vo A
Transplant Proc; 2012 Jan; 44(1):60-1. PubMed ID: 22310579
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
Jordan SC; Tyan D; Stablein D; McIntosh M; Rose S; Vo A; Toyoda M; Davis C; Shapiro R; Adey D; Milliner D; Graff R; Steiner R; Ciancio G; Sahney S; Light J
J Am Soc Nephrol; 2004 Dec; 15(12):3256-62. PubMed ID: 15579530
[TBL] [Abstract][Full Text] [Related]
6. Analysis of anti-HLA antibodies in sensitized kidney transplant candidates subjected to desensitization with intravenous immunoglobulin and rituximab.
Lobashevsky AL; Higgins NG; Rosner KM; Mujtaba MA; Goggins WC; Taber TE
Transplantation; 2013 Jul; 96(2):182-90. PubMed ID: 23778648
[TBL] [Abstract][Full Text] [Related]
7. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
Yuan XP; Wang CX; Gao W; Fu Q; He XS
Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D
Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100
[TBL] [Abstract][Full Text] [Related]
9. Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients.
Montgomery RA; Lonze BE; Jackson AM
Curr Opin Organ Transplant; 2011 Aug; 16(4):439-43. PubMed ID: 21666478
[TBL] [Abstract][Full Text] [Related]
10. Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy.
Lai CH; Cao K; Ong G; Naim M; Wang Q; Mirocha J; Vo A; Jordan SC; Reinsmoen NL
Transplantation; 2011 Jul; 92(1):48-53. PubMed ID: 21562450
[TBL] [Abstract][Full Text] [Related]
11. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
[TBL] [Abstract][Full Text] [Related]
12. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
[TBL] [Abstract][Full Text] [Related]
13. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
[TBL] [Abstract][Full Text] [Related]
14. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
15. Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.
Patel J; Everly M; Chang D; Kittleson M; Reed E; Kobashigawa J
J Heart Lung Transplant; 2011 Dec; 30(12):1320-6. PubMed ID: 21968130
[TBL] [Abstract][Full Text] [Related]
16. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
17. Intravenous human immunoglobulin treatment of serum from HLA-sensitized patients in kidney transplantation.
Picascia A; Grimaldi V; Paolillo R; Vasco M; Casamassimi A; De Luca FP; Cavalca F; Schiano C; Napoli C
Ren Fail; 2014 May; 36(4):585-8. PubMed ID: 24456257
[TBL] [Abstract][Full Text] [Related]
18. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients.
Valentini RP; Nehlsen-Cannarella SL; Gruber SA; Mattoo TK; West MS; Lang C; Imam AA
Pediatr Transplant; 2007 Feb; 11(1):77-81. PubMed ID: 17239127
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
